Approxima

Approxima is a percutaneous tricuspid repair system developed by the company, currently undergoing preclinical feasibility studies to demonstrate its viability, efficacy, and safety in vivo. Approxima is the device capable of counteracting ventricular dilation, which causes tricuspid and right heart failure. Functional prototypes of the device have been developed and tested in an ex-vivo environment, and the technology is protected by national patents and PCT applications.
Approxima是該公司研發的一種經皮三尖瓣修復系統，目前正在進行臨床前可行性階段的研究，以證明其在活體中的可行性、有效性和安全性。Approxima是能夠對抗引起三尖瓣和右心衰竭的心室擴張的裝置，其功能原型已經在體外環境中開發並測試，且技術受國家專利和PCT申請保護。